Skip to main content
LLM 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Session X: Upfront Treatment of Myeloma

Friday, October 20, 2023
10:00 AM – 11:55 AM ET
Location: Metropolitan East

Talks in this session are supported by Janssen Biotech Inc, administered by Janssen Scientific Affairs, LLC and Karyopharm Therapeutics.

Presentations:

  • 10:00 AM – 10:05 AM ET
    Pre-Session Audience Survey
  • 10:05 AM – 10:25 AM ET
    Management of The Frail and Transplant Ineligible Patient

    Speaker: María-Victoria Mateos, PhD – University Hospital of Salamanca

  • 10:25 AM – 10:45 AM ET
    Management of High-risk Patient: How do we Define? Should there be a Novel Approach?

    Speaker: Suzanne Lentszch, MD, PhD – Columbia University Medical Center

  • 10:45 AM – 11:05 AM ET
    Maintenance Therapy: Should CD38 ab or Bispecifics be Incorporated? Does MRD Inform Type or Duration Maintenance?

    Speaker: Ajai Chari, MD – UCSF

  • 11:05 AM – 11:20 AM ET
    Debate: Management of a Fit Patient: Should CAR-T Replace Autotransplant as Consolidation? - TRANSPLANT

    Debate Speaker: Sergio Giralt, MD, FACP, FASTCT – Memorial Sloan Kettering Cancer Center

  • 11:20 AM – 11:35 AM ET
    Debate: Management of a Fit Patient: Should CAR-T Replace Autotransplant as Consolidation? - CAR-T

    Debate Speaker: Adriana Rossi, MD – Mount Sinai School of Medicine

  • 11:35 AM – 11:55 AM ET
    Panel Discussion and Post-Session Audience Survey

    Panelist: Ajai Chari, MD – UCSF

    Panelist: Sergio Giralt, MD, FACP, FASTCT – Memorial Sloan Kettering Cancer Center

    Panelist: Suzanne Lentszch, MD, PhD – Columbia University Medical Center

    Panelist: María-Victoria Mateos, PhD – University Hospital of Salamanca

    Panelist: Adriana Rossi, MD – Mount Sinai School of Medicine